These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 833762)

  • 1. Metabolic clearance of furosemide in the rat.
    Wallin JD; Ryals P; Kaplowitz N
    J Pharmacol Exp Ther; 1977 Jan; 200(1):52-7. PubMed ID: 833762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of phenobarbital, probenecid and diethyl maleate on the pharmaco-kinetics and biliary excretion of ethacrynic acid in the rat.
    Wallin JD; Clifton G; Kaplowitz N
    J Pharmacol Exp Ther; 1978 May; 205(2):471-9. PubMed ID: 641842
    [No Abstract]   [Full Text] [Related]  

  • 3. Probenecid inhibits the renal clearance of frusemide and its acyl glucuronide.
    Vree TB; van den Biggelaar-Martea M; Verwey-van Wissen CP
    Br J Clin Pharmacol; 1995 Jun; 39(6):692-5. PubMed ID: 7654491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic, biliary excretion, and metabolic studies of 14C-furosemide in the rat.
    Prandota J; Pruitt AW
    Xenobiotica; 1991 Jun; 21(6):725-36. PubMed ID: 1949904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clearance of furosemide by the gastrointestinal tract.
    Valentine JF; Brater DC; Krejs GJ
    J Pharmacol Exp Ther; 1986 Jan; 236(1):177-80. PubMed ID: 3941391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of experimental azotemia on renal clearance of furosemide in the dog.
    Rose HJ; Pruitt AW; McNay JL
    J Pharmacol Exp Ther; 1976 Jan; 196(1):238-47. PubMed ID: 1246013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the kidneys in the metabolism of furosemide: its inhibition by probenecid.
    Pichette V; du Souich P
    J Am Soc Nephrol; 1996 Feb; 7(2):345-9. PubMed ID: 8785407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of binding in distribution of furosemide: where is nonrenal clearance?
    Branch RA
    Fed Proc; 1983 Apr; 42(6):1699-702. PubMed ID: 6832389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of biliary excretion of methotrexate by probenecid in rats: quantitative prediction of interaction from in vitro data.
    Ueda K; Kato Y; Komatsu K; Sugiyama Y
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1036-43. PubMed ID: 11356926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nonprimate animal model applicable to zidovudine pharmacokinetics in humans: inhibition of glucuronidation and renal excretion of zidovudine by probenecid in rats.
    Mays DC; Dixon KF; Balboa A; Pawluk LJ; Bauer MR; Nawoot S; Gerber N
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1261-70. PubMed ID: 1762074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanism of renal clearance of cisplatin (cis-dichlorodiammine platinum ii) and its modification by furosemide and probenecid.
    Daley-Yates PT; McBrien DC
    Biochem Pharmacol; 1982 Jul; 31(13):2243-6. PubMed ID: 6889863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of probenecid upon the individual components of indomethacin elimination.
    Duggan DE; Hooke KF; White SD; Noll RM; Stevenson CR
    J Pharmacol Exp Ther; 1977 May; 201(2):463-70. PubMed ID: 404419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary evaluation of furosemide-probenecid interaction in humans.
    Smith DE; Gee WL; Brater DC; Lin ET; Benet LZ
    J Pharm Sci; 1980 May; 69(5):571-5. PubMed ID: 7381747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probenecid-impaired biliary excretion of acetaminophen glucuronide and sulfate in the rat.
    Savina PM; Brouwer KL
    Drug Metab Dispos; 1992; 20(4):496-501. PubMed ID: 1356724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probenecid protects against In vivo acetaminophen-induced nephrotoxicity in male Wistar rats.
    Trumper L; Monasterolo LA; Elías MM
    J Pharmacol Exp Ther; 1998 Feb; 284(2):606-10. PubMed ID: 9454804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonrenal clearance of furosemide as a cause of diuretic response variability in the rat.
    Lambert C; Caillé G; du Souich P
    J Pharmacol Exp Ther; 1982 Jul; 222(1):232-6. PubMed ID: 7086701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cimetidine, probenecid, and ketoconazole on the distribution, biliary secretion, and metabolism of [3H]taxol in the Sprague-Dawley rat.
    Klecker RW; Jamis-Dow CA; Egorin MJ; Erkmen K; Parker RJ; Stevens R; Collins JM
    Drug Metab Dispos; 1994; 22(2):254-8. PubMed ID: 7912177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of furosemide in functionally hepatectomized dogs.
    Verbeeck RK; Gerkens JF; Wilkinson GR; Branch RA
    J Pharmacol Exp Ther; 1981 Mar; 216(3):479-83. PubMed ID: 7205627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of probenecid and spironolactone on furosemide kinetics and dynamics in man.
    Homeida M; Roberts C; Branch RA
    Clin Pharmacol Ther; 1977 Oct; 22(4):402-9. PubMed ID: 902453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered hepatobiliary disposition of acetaminophen metabolites after phenobarbital pretreatment and renal ligation: evidence for impaired biliary excretion and a diffusional barrier.
    Brouwer KL; Jones JA
    J Pharmacol Exp Ther; 1990 Feb; 252(2):657-64. PubMed ID: 2313593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.